Cargando…
PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives
Autores principales: | Kong, Yi Wen, Dreaden, Erik C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092184/ https://www.ncbi.nlm.nih.gov/pubmed/35573237 http://dx.doi.org/10.3389/fbioe.2022.879988 |
Ejemplares similares
-
Modification of PEG reduces the immunogenicity of biosynthetic gas vesicles
por: Wang, Yuanyuan, et al.
Publicado: (2023) -
Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines
por: Padín-González, Esperanza, et al.
Publicado: (2022) -
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
por: Kozma, Gergely Tibor, et al.
Publicado: (2023) -
PEG-fibrinogen hydrogel microspheres as a scaffold for therapeutic delivery of immune cells
por: Cohen, Noam, et al.
Publicado: (2022) -
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
por: Hoang Thi, Thai Thanh, et al.
Publicado: (2020)